Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Automation/Robot

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1732203

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1732203

Exoskeleton Market by Component, Functionality, Type, Body Part - Global Forecast to 2030

PUBLISHED:
PAGES: 255 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The exoskeleton market is estimated to be USD 0.56 billion in 2025 and is projected to reach USD 2.03 billion by 2030, registering a CAGR of 29.4% during the forecast period. Exoskeletons are important for improving mobility for people with physical impairment and reducing physical strain for industrial workers, leading to the integration of exoskeletons in healthcare and manufacturing. As the elderly population increases and patients at home for rehabilitation become more prevalent, the need for exoskeletons will only rise. As more technologies become available (AI, sensors, lightweight materials), exoskeleton products will function better, cheaper, and be more available. The process of product development and the growth of the exoskeleton market internationally will only be improved by continued investments by both the public and private sectors.

Scope of the Report
Years Considered for the Study2020-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD Million)
SegmentsBy Component, Functionality, Type, Body Part and Region
Regions coveredNorth America, Europe, APAC, RoW

"Powered exoskeleton segment to register the highest CAGR during the forecast period."

The market for powered exoskeletons is experiencing accelerated growth, fueled by significant funding activities that underscore rising investor confidence and commercialization potential. For instance, in December 2023, German Bionic, a developer of electrically powered exoskeletons, secured more than USD 16.3 million in an expanded Series A funding round. This funding is aimed at strengthening the company's collaboration with its industrialization partner, Mubea, to scale production and improve deployment capabilities. In the same month, Verve Motion, a Cambridge-based startup specializing in robotic exosuits designed to enhance the physical capabilities of workers in demanding roles, successfully raised USD 20 million in a Series B funding round. These developments reflect a broader trend of strategic investments in powered exoskeleton technologies, positioning them as viable solutions for industrial automation, injury prevention, and workforce augmentation across various sectors.

"Industrial vertical to register the second-highest CAGR during the forecast period."

The industrial sector is rapidly emerging as a significant adopter of exoskeleton technology, driven by the need to improve worker safety, reduce fatigue, and increase productivity in labor-intensive environments. Exoskeletons are particularly useful in industries such as manufacturing, warehousing, logistics, and assembly lines, where workers often perform repetitive lifting, bending, and overhead tasks. By supporting the lower back, shoulders, and legs, these wearable devices help reduce the risk of musculoskeletal injuries, one of the most common causes of lost workdays and rising occupational health costs.

"Germany to dominate European exoskeleton market."

Germany represents one of the most advanced and mature markets for exoskeleton technology in Europe, driven by strong industrial demand, innovation in healthcare, and significant private investments. The country's robust manufacturing and logistics sectors are actively adopting exoskeletons to improve workforce efficiency and reduce musculoskeletal injuries. German Bionic, a leading domestic developer, exemplifies this trend. In December 2023, the company raised over USD 16.3 million in an expanded Series A funding round to advance its product portfolio. Its exoskeletons, Apogee and Apogee+, are used in logistics, retail, and healthcare settings to assist with lifting, walking, and posture correction. These connected wearables are helping redefine workplace ergonomics across Germany's key industries.

  • By Company Type: Tier 1 - 25%, Tier 2 - 40%, and Tier 3 - 35%
  • By Designation: C-level Executives - 30%, Directors - 28%, and Others - 42%
  • By Region: North America- 43%, Europe - 15%, Asia Pacific- 37%, and RoW- 05%

Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), ABLE Human Motion (Spain), Laevo Exoskeletons (Netherlands), German Bionic Systems GmbH (Germany), and Levitate Technologies, Inc. (US) are some of the key players in the exoskeleton market.

The study includes an in-depth competitive analysis of these key players in the exoskeleton market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the exoskeleton market by component (hardware, software), type (powered, passive, hybrid), body part (lower extremities, upper extremities, full body), structure (rigid, soft), mobility (stationary, mobile), vertical (healthcare, defense, industrial, construction, other verticals), and region (North America, Europe, Asia Pacific, and RoW). The report's scope covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the exoskeleton market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies (contracts, partnerships, agreements, new product launches, mergers & acquisitions); and recent developments associated with the exoskeleton market. This report covers the competitive analysis of upcoming startups in the exoskeleton market ecosystem.

Reasons to Buy This Report

The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall exoskeleton market and its subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Rising demand for robotic rehabilitation solutions from healthcare sector, Increased adoption in industrial and manufacturing sectors, Increased FDA approvals for medical exoskeletons), restraints (High cost of ownership), opportunities (Integration of exoskeletons with AI and IoT technologies, Increasing adoption of exoskeletons in military and defense sector), and challenges (Comfort and movement interference for workers, Power supply limitations and operational downtime) influencing the growth of the exoskeleton market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the exoskeleton market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the exoskeleton market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the exoskeleton market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), ABLE Human Motion (Spain), Laevo Exoskeletons (Netherlands), German Bionic Systems GmbH (Germany), Levitate Technologies, Inc. (US), among others in the exoskeleton market.
Show more
Product Code: SE 5773

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
    • 1.3.2 YEARS CONSIDERED
    • 1.3.3 INCLUSIONS AND EXCLUSIONS
  • 1.4 CURRENCY CONSIDERED
  • 1.5 UNITS CONSIDERED
  • 1.6 LIMITATIONS
  • 1.7 STAKEHOLDERS
  • 1.8 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 List of major secondary sources
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Intended participants and key opinion leaders in primary interviews
      • 2.1.2.2 List of major participants in primary interviews
      • 2.1.2.3 Key data from primary sources
      • 2.1.2.4 Breakdown of primary interviews
    • 2.1.3 SECONDARY AND PRIMARY RESEARCH
      • 2.1.3.1 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach to arrive at market size using bottom-up analysis (demand side)
    • 2.2.2 TOP-DOWN APPROACH
      • 2.2.2.1 Approach to arrive at market size using top-down analysis (supply side)
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS
  • 2.6 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN EXOSKELETON MARKET
  • 4.2 EXOSKELETON MARKET IN NORTH AMERICA, BY COUNTRY AND VERTICAL
  • 4.3 EXOSKELETON MARKET IN ASIA PACIFIC, BY VERTICAL
  • 4.4 EXOSKELETON MARKET, BY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising demand for robotic rehabilitation solutions from healthcare sector
      • 5.2.1.2 Increased adoption in industrial and manufacturing sectors
      • 5.2.1.3 Increased FDA approvals for medical exoskeletons
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High cost of ownership
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Integration of exoskeletons with AI and IoT technologies
      • 5.2.3.2 Increasing adoption of exoskeletons in military and defense sectors
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Comfort and movement interference for workers
      • 5.2.4.2 Power supply limitations and operational downtime
  • 5.3 VALUE CHAIN ANALYSIS
  • 5.4 ECOSYSTEM ANALYSIS
  • 5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.6 PRICING ANALYSIS
    • 5.6.1 PRICING RANGE OF EXOSKELETON OFFERED BY KEY PLAYERS, BY TYPE, 2024
    • 5.6.2 AVERAGE SELLING PRICE TREND OF EXOSKELETON, BY TYPE, 2022-2024
    • 5.6.3 AVERAGE SELLING PRICE TREND OF POWERED EXOSKELETON, BY REGION, 2022-2024
    • 5.6.4 AVERAGE SELLING PRICE TREND OF PASSIVE EXOSKELETON, BY REGION, 2022-2024
  • 5.7 TECHNOLOGY ANALYSIS
    • 5.7.1 KEY TECHNOLOGIES
      • 5.7.1.1 Actuators and motors
      • 5.7.1.2 Sensors and feedback systems
    • 5.7.2 COMPLEMENTARY TECHNOLOGIES
      • 5.7.2.1 IoT connectivity
      • 5.7.2.2 AI and ML
    • 5.7.3 ADJACENT TECHNOLOGIES
      • 5.7.3.1 Artificial muscles
      • 5.7.3.2 Physical therapy equipment
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 INTENSITY OF COMPETITIVE RIVALRY
    • 5.8.2 BARGAINING POWER OF SUPPLIERS
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 THREAT OF SUBSTITUTES
    • 5.8.5 THREAT OF NEW ENTRANTS
  • 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.9.2 BUYING CRITERIA
  • 5.10 CASE STUDY ANALYSIS
    • 5.10.1 ENHANCING WORKER ERGONOMICS AND PRODUCTIVITY AT JOHN DEERE WITH COMAU'S MATE-XT WEARABLE EXOSKELETON
    • 5.10.2 ENHANCING LOGISTICS OPERATIONS AND WORKER WELL-BEING AT FIEGE GROUP WITH GERMAN BIONIC AI-POWERED EXOSKELETON TECHNOLOGY
    • 5.10.3 ENHANCING WORKER SAFETY AND PRODUCTIVITY IN TUNNEL CONSTRUCTION AT GRANITE CONSTRUCTION WITH LEVITATE TECHNOLOGIES EXOSKELETONS
    • 5.10.4 REDUCING PHYSICAL STRAIN IN TRUCK MAINTENANCE AT MAN TRUCK & BUS WITH HELP OF SUITX TECHNOLOGY BY OTTOBOCK
    • 5.10.5 FORD MOTOR COMPANY ENHANCES WORKER SAFETY AND REDUCES INJURIES WITH EKSO BIONICS EKSOVEST
  • 5.11 INVESTMENT AND FUNDING SCENARIO
  • 5.12 TRADE ANALYSIS, 2020-2024
    • 5.12.1 IMPORT SCENARIO (HS CODE 9021)
    • 5.12.2 EXPORT SCENARIO (HS CODE 9021)
  • 5.13 PATENT ANALYSIS
  • 5.14 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.15 TARIFF AND REGULATORY LANDSCAPE
    • 5.15.1 TARIFF ANALYSIS, 2024
    • 5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.15.3 STANDARDS
  • 5.16 IMPACT OF AI ON EXOSKELETON MARKET
    • 5.16.1 INTRODUCTION
    • 5.16.2 AI-SPECIFIC USE CASES
  • 5.17 2025 US TARIFF IMPACT ON EXOSKELETON MARKET
    • 5.17.1 INTRODUCTION
    • 5.17.2 KEY TARIFF RATES
    • 5.17.3 PRICE IMPACT ANALYSIS
    • 5.17.4 KEY IMPACTS ON VARIOUS COUNTRIES/REGIONS
      • 5.17.4.1 US
      • 5.17.4.2 Europe
      • 5.17.4.3 Asia Pacific
    • 5.17.5 END-USE INDUSTRY IMPACT

6 EXOSKELETON MARKET, BY MATERIAL

  • 6.1 INTRODUCTION
  • 6.2 CARBON FIBER
    • 6.2.1 GROWING EMPHASIS ON LIGHTWEIGHT MATERIALS IN WEARABLE ROBOTICS TO DRIVE MARKET
  • 6.3 METAL
    • 6.3.1 HIGH STRUCTURAL STRENGTH AND LOAD-BEARING CAPACITY TO DRIVE DEMAND
  • 6.4 STEEL ALLOYS
    • 6.4.1 SUPERIOR DURABILITY IN HARSH WORK ENVIRONMENTS TO DRIVE MARKET
  • 6.5 ALUMINUM
    • 6.5.1 CORROSION RESISTANCE AND LIGHTWEIGHT DESIGN TO FUEL SEGMENT GROWTH

7 EXOSKELETON MARKET, BY STRUCTURE

  • 7.1 INTRODUCTION
  • 7.2 RIGID EXOSKELETONS
    • 7.2.1 RISING DEMAND FOR REHABILITATION THERAPIES TO DRIVE MARKET
  • 7.3 SOFT EXOSKELETONS
    • 7.3.1 INCREASING STARTUP FUNDING AND EXPANDING USE IN PERSONAL STRUCTURE TO DRIVE MARKET

8 EXOSKELETON MARKET, BY MOBILITY

  • 8.1 INTRODUCTION
  • 8.2 STATIONARY
    • 8.2.1 RISING DEMAND FOR REHABILITATION THERAPIES TO DRIVE MARKET
  • 8.3 MOBILE
    • 8.3.1 RISING STARTUP FUNDING AND EXPANDING USE IN PERSONAL MOBILITY TO DRIVE MARKET

9 EXOSKELETON MARKET, BY BODY PART

  • 9.1 INTRODUCTION
  • 9.2 LOWER EXTREMITIES
    • 9.2.1 RISING PREVALENCE OF SPINAL CORD INJURIES TO BOOST MARKET DEMAND
  • 9.3 UPPER EXTREMITIES
    • 9.3.1 ADVANCEMENTS IN PASSIVE AND LIGHTWEIGHT EXOSKELETONS TO DRIVE MARKET
  • 9.4 FULL BODY
    • 9.4.1 ADOPTION IN COMPLEX REHABILITATION PROGRAMS AND RISING USE IN HEAVY INDUSTRIAL APPLICATIONS TO FUEL DEMAND

10 EXOSKELETON MARKET, BY COMPONENT

  • 10.1 INTRODUCTION
  • 10.2 SENSORS
    • 10.2.1 INTEGRATION OF AI AND ML TO BOOST DEMAND
    • 10.2.2 GYROSCOPES
    • 10.2.3 ACCELEROMETERS
    • 10.2.4 TILT SENSORS
    • 10.2.5 FORCE/TORQUE SENSORS
    • 10.2.6 POSITION SENSORS
    • 10.2.7 ELECTROMYOGRAPHY SENSORS
  • 10.3 ACTUATORS
    • 10.3.1 COMPATIBILITY WITH ADVANCED CONTROLLERS AND SENSORS FOR REAL-TIME MOTION COORDINATION TO DRIVE MARKET
  • 10.4 POWER SOURCES
    • 10.4.1 ADVANCEMENTS IN BATTERY TECHNOLOGIES TO BOOST MARKET
  • 10.5 CONTROL SYSTEMS
    • 10.5.1 ADVANCEMENTS IN ML AND REAL-TIME DATA PROCESSING TO DRIVE MARKET
  • 10.6 OTHER COMPONENTS

11 EXOSKELETON MARKET, BY TYPE

  • 11.1 INTRODUCTION
  • 11.2 POWERED EXOSKELETON
    • 11.2.1 RISING ADOPTION OF ROBOTIC ASSISTANCE IN REHABILITATION AND MOBILITY SUPPORT FOR PATIENTS TO FUEL MARKET GROWTH
    • 11.2.2 POWERED EXOSKELETONS, BY TECHNOLOGY
      • 11.2.2.1 Advancements in battery technology and energy-efficient actuators to fuel market growth
      • 11.2.2.2 Electric
      • 11.2.2.3 Pneumatic
      • 11.2.2.4 Hydraulic
  • 11.3 PASSIVE EXOSKELETON
    • 11.3.1 INCREASING FOCUS ON WORKPLACE ERGONOMICS AND INJURY PREVENTION TO FUEL ADOPTION

12 EXOSKELETON MARKET, BY VERTICAL

  • 12.1 INTRODUCTION
  • 12.2 HEALTHCARE
    • 12.2.1 RISING FDA CLEARANCE AND STARTUP FUNDING TO FUEL GROWTH OF MEDICAL EXOSKELETONS SEGMENT
    • 12.2.2 REHABILITATION
    • 12.2.3 DISABILITY ASSISTANCE
    • 12.2.4 ELDERLY CARE
  • 12.3 DEFENSE
    • 12.3.1 INCREASING DEMAND FOR ENHANCED SOLDIER PERFORMANCE AND OPERATIONAL EFFICIENCY TO COMPLEMENT MARKET GROWTH
    • 12.3.2 ENHANCED MOBILITY
    • 12.3.3 INJURY PREVENTION
    • 12.3.4 STEALTH AND TACTICAL OPERATIONS
  • 12.4 INDUSTRIAL
    • 12.4.1 INCREASED FOCUS ON WORKPLACE SAFETY AND COMPLIANCE TO DRIVE MARKET
    • 12.4.2 HEAVY LIFTING
    • 12.4.3 REPETITIVE TASK ASSISTANCE
    • 12.4.4 POSTURAL SUPPORT
    • 12.4.5 LOGISTICS
    • 12.4.6 MATERIAL HANDLING
  • 12.5 CONSTRUCTION
    • 12.5.1 INCREASING FOCUS ON WORKER HEALTH TO FUEL ADOPTION OF EXOSKELETONS
    • 12.5.2 LIFTING ASSISTANCE
    • 12.5.3 ENHANCED PRODUCTIVITY AND EFFICIENCY
  • 12.6 OTHER VERTICALS

13 EXOSKELETON MARKET, BY REGION

  • 13.1 INTRODUCTION
  • 13.2 NORTH AMERICA
    • 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 13.2.2 US
      • 13.2.2.1 Growing military focus on injury prevention and surge in startup funding to drive market
    • 13.2.3 CANADA
      • 13.2.3.1 Government contracts supporting defense applications to boost market
    • 13.2.4 MEXICO
      • 13.2.4.1 Strategic investments in hospital infrastructure to foster revenue growth
  • 13.3 EUROPE
    • 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 13.3.2 UK
      • 13.3.2.1 Government support through defense innovation program to propel market
    • 13.3.3 GERMANY
      • 13.3.3.1 Presence of leading exoskeleton manufacturers and startups to complement revenue growth
    • 13.3.4 FRANCE
      • 13.3.4.1 Strong public and private investment in MedTech to boost market
    • 13.3.5 ITALY
      • 13.3.5.1 Strong collaboration between research institutes and industry to drive market
    • 13.3.6 POLAND
      • 13.3.6.1 Strategic partnerships with global exoskeleton providers to drive market
    • 13.3.7 NORDICS
      • 13.3.7.1 Academic and institutional R&D in robotics to drive market
    • 13.3.8 REST OF EUROPE
  • 13.4 ASIA PACIFIC
    • 13.4.1 MACRO ECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 13.4.2 CHINA
      • 13.4.2.1 Military investment in wearable robotics for logistics and mobility to boost market
    • 13.4.3 JAPAN
      • 13.4.3.1 Rapidly aging population and government support to create lucrative market growth opportunities
    • 13.4.4 SOUTH KOREA
      • 13.4.4.1 Advancements in lightweight, AI-integrated wearable robotics systems to drive market
    • 13.4.5 INDIA
      • 13.4.5.1 Military adoption for enhanced soldier endurance and injury prevention to boost market
    • 13.4.6 AUSTRALIA
      • 13.4.6.1 High healthcare spending to encourage adoption of advanced assistive technologies and boost demand
    • 13.4.7 INDONESIA
      • 13.4.7.1 High paraplegic population demanding affordable mobility rehabilitation solutions to drive market
    • 13.4.8 MALAYSIA
      • 13.4.8.1 Rising demand for rehabilitation devices that support patient mobility recovery to create growth opportunities
    • 13.4.9 THAILAND
      • 13.4.9.1 Government-backed research funding to boost exoskeleton technology development
    • 13.4.10 VIETNAM
      • 13.4.10.1 Increased research initiatives by domestic academic and medical institutions to drive market
    • 13.4.11 REST OF ASIA PACIFIC
  • 13.5 REST OF THE WORLD
    • 13.5.1 MACROECONOMIC OUTLOOK FOR ROW
    • 13.5.2 MIDDLE EAST
      • 13.5.2.1 Bahrain
        • 13.5.2.1.1 Growing adoption of smart transportation and home automation to drive demand
      • 13.5.2.2 Kuwait
        • 13.5.2.2.1 Focus on improving healthcare accessibility and patient outcomes to fuel market
      • 13.5.2.3 Oman
        • 13.5.2.3.1 Rising prevalence of neurological and musculoskeletal disorders to drive market
      • 13.5.2.4 Qatar
        • 13.5.2.4.1 Strategic focus on defense modernization and soldier performance to increase market demand
      • 13.5.2.5 Saudi Arabia
        • 13.5.2.5.1 Vision 2030 focus on healthcare innovation and technology adoption to fuel market
      • 13.5.2.6 UAE
        • 13.5.2.6.1 Investment in R&D of intelligent robotic systems to drive market
      • 13.5.2.7 Rest of the Middle East
    • 13.5.3 SOUTH AMERICA
      • 13.5.3.1 Partnerships with global exoskeleton technology providers and manufacturers to support market
    • 13.5.4 AFRICA
    • 13.5.5 SOUTH AFRICA
      • 13.5.5.1 Focus on improving worker safety in high-risk mining operations to drive market
    • 13.5.6 OTHER AFRICAN COUNTRIES

14 COMPETITIVE LANDSCAPE

  • 14.1 OVERVIEW
  • 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2022-FEBRUARY 2025
  • 14.3 REVENUE ANALYSIS, 2019-2023
  • 14.4 MARKET SHARE ANALYSIS, 2024
  • 14.5 COMPANY VALUATION AND FINANCIAL METRICS, 2024
  • 14.6 BRAND/PRODUCT COMPARISON
  • 14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 14.7.1 STARS
    • 14.7.2 EMERGING LEADERS
    • 14.7.3 PERVASIVE PLAYERS
    • 14.7.4 PARTICIPANTS
    • 14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
      • 14.7.5.1 Company footprint
      • 14.7.5.2 Region footprint
      • 14.7.5.3 Vertical footprint
      • 14.7.5.4 Type footprint
      • 14.7.5.5 Body part footprint
  • 14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 14.8.1 PROGRESSIVE COMPANIES
    • 14.8.2 RESPONSIVE COMPANIES
    • 14.8.3 DYNAMIC COMPANIES
    • 14.8.4 STARTING BLOCKS
    • 14.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2024
      • 14.8.5.1 Detailed list of startups/SMEs
      • 14.8.5.2 Competitive benchmarking of key startups/SMEs
  • 14.9 COMPETITIVE SCENARIO
    • 14.9.1 PRODUCT LAUNCHES
    • 14.9.2 DEALS
    • 14.9.3 EXPANSIONS
    • 14.9.4 OTHER DEVELOPMENTS

15 COMPANY PROFILES

  • 15.1 KEY PLAYERS
    • 15.1.1 EKSO BIONICS
      • 15.1.1.1 Business overview
      • 15.1.1.2 Products/Solutions/Services offered
      • 15.1.1.3 Recent developments
        • 15.1.1.3.1 Product launches
        • 15.1.1.3.2 Deals
        • 15.1.1.3.3 Other developments
      • 15.1.1.4 MnM view
        • 15.1.1.4.1 Key strengths/Right to win
        • 15.1.1.4.2 Strategic choices
        • 15.1.1.4.3 Weaknesses and competitive threats
    • 15.1.2 OTTOBOCK
      • 15.1.2.1 Business overview
      • 15.1.2.2 Products/Solutions/Services offered
      • 15.1.2.3 Recent developments
        • 15.1.2.3.1 Product launches
      • 15.1.2.4 MnM view
        • 15.1.2.4.1 Key strengths/Right to win
        • 15.1.2.4.2 Strategic choices
        • 15.1.2.4.3 Weaknesses and competitive threats
    • 15.1.3 DIH MEDICAL
      • 15.1.3.1 Business overview
      • 15.1.3.2 Products/Solutions/Services offered
      • 15.1.3.3 Recent developments
        • 15.1.3.3.1 Deals
      • 15.1.3.4 MnM view
        • 15.1.3.4.1 Key strengths/Right to win
        • 15.1.3.4.2 Strategic choices
        • 15.1.3.4.3 Weaknesses and competitive threats
    • 15.1.4 COMAU
      • 15.1.4.1 Business overview
      • 15.1.4.2 Products/Solutions/Services offered
      • 15.1.4.3 Recent developments
        • 15.1.4.3.1 Product launches
      • 15.1.4.4 MnM view
        • 15.1.4.4.1 Key strengths/Right to win
        • 15.1.4.4.2 Strategic choices
        • 15.1.4.4.3 Weaknesses and competitive threats
    • 15.1.5 MYOMO INC.
      • 15.1.5.1 Business overview
      • 15.1.5.2 Products/Solutions/Services offered
      • 15.1.5.3 Recent developments
        • 15.1.5.3.1 Product launches
        • 15.1.5.3.2 Other developments
      • 15.1.5.4 MnM view
        • 15.1.5.4.1 Key strengths/Right to win
        • 15.1.5.4.2 Strategic choices
        • 15.1.5.4.3 Weaknesses and competitive threats
    • 15.1.6 CYBERDYNE INC.
      • 15.1.6.1 Business overview
      • 15.1.6.2 Products/Solutions/Services offered
      • 15.1.6.3 Recent developments
        • 15.1.6.3.1 Expansions
    • 15.1.7 LIFEWARD LTD.
      • 15.1.7.1 Business overview
      • 15.1.7.2 Products/Solutions/Services offered
      • 15.1.7.3 Recent developments
        • 15.1.7.3.1 Deals
    • 15.1.8 HYUNDAI MOTOR GROUP ROBOTICS LAB.
      • 15.1.8.1 Business overview
      • 15.1.8.2 Products/Solutions/Services offered
      • 15.1.8.3 Recent developments
        • 15.1.8.3.1 Product launches
        • 15.1.8.3.2 Deals
    • 15.1.9 B-TEMIA
      • 15.1.9.1 Business overview
      • 15.1.9.2 Products/Solutions/Services offered
    • 15.1.10 REX BIONICS LTD.
      • 15.1.10.1 Business overview
      • 15.1.10.2 Products/Solutions/Services offered
  • 15.2 OTHER PLAYERS
    • 15.2.1 ABLE HUMAN MOTION
    • 15.2.2 LAEVO EXOSKELETONS
    • 15.2.3 GERMAN BIONIC SYSTEMS GMBH
    • 15.2.4 LEVITATE TECHNOLOGIES, INC.
    • 15.2.5 FOURIER
    • 15.2.6 TREXO ROBOTICS
    • 15.2.7 WANDERCRAFT
    • 15.2.8 AGADE
    • 15.2.9 EUROPE TECHNOLOGIES
    • 15.2.10 GOGOA.EU
    • 15.2.11 ARCHELIS INC.
    • 15.2.12 P&S MECHANICS CO., LTD.
    • 15.2.13 RB3D
    • 15.2.14 JAPET MEDICAL DEVICES
    • 15.2.15 PROTESO S.R.L.

16 APPENDIX

  • 16.1 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.2 CUSTOMIZATION OPTIONS
  • 16.3 RELATED REPORTS
  • 16.4 AUTHOR DETAILS
Show more
Product Code: SE 5773

List of Tables

  • TABLE 1 EXOSKELETON MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 2 PRICING RANGE OF EXOSKELETON OFFERED BY KEY PLAYERS, BY TYPE (USD), 2024
  • TABLE 3 AVERAGE SELLING PRICE TREND OF EXOSKELETON, BY TYPE, 2022-2024 (USD)
  • TABLE 4 AVERAGE SELLING PRICE TREND OF POWERED EXOSKELETON, BY REGION (USD), 2022-2024
  • TABLE 5 AVERAGE SELLING PRICE TREND OF PASSIVE EXOSKELETON, BY REGION (USD), 2022-2024
  • TABLE 6 EXOSKELETON MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR EXOSKELETONS FOR TOP THREE VERTICALS
  • TABLE 8 KEY BUYING CRITERIA FOR EXOSKELETONS FOR TOP THREE VERTICALS
  • TABLE 9 IMPORT SCENARIO FOR HS CODE 9021-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 10 EXPORT SCENARIO FOR HS CODE 9021-COMPLIANT PRODUCTS, BY COUNTRY, 2020-2024 (USD MILLION)
  • TABLE 11 EXOSKELETON MARKET: LIST OF MAJOR PATENTS, 2022-2024
  • TABLE 12 EXOSKELETON MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 13 MFN TARIFF FOR HS CODE 9021-COMPLIANT PRODUCTS EXPORTED BY US, 2024
  • TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 US-ADJUSTED RECIPROCAL TARIFF RATES, 2024 (USD BILLION)
  • TABLE 19 EXPECTED CHANGE IN PRICES AND IMPACT ON END-USE MARKETS DUE TO TARIFF IMPACT
  • TABLE 20 EXOSKELETON MARKET, BY MOBILITY, 2021-2024 (USD MILLION)
  • TABLE 21 EXOSKELETON MARKET, BY MOBILITY, 2025-2030 (USD MILLION)
  • TABLE 22 STATIONARY: EXOSKELETON MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 23 STATIONARY: EXOSKELETON MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 24 MOBILE: EXOSKELETON MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 25 MOBILE: EXOSKELETON MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 26 EXOSKELETON MARKET, BY BODY PART, 2021-2024 (USD MILLION)
  • TABLE 27 EXOSKELETON MARKET, BY BODY PART, 2025-2030 (USD MILLION)
  • TABLE 28 LOWER EXTREMITIES: EXOSKELETON MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 29 LOWER EXTREMITIES: EXOSKELETON MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 30 UPPER EXTREMITIES: EXOSKELETON MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 31 UPPER EXTREMITIES: EXOSKELETON MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 32 FULL BODY: EXOSKELETON MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 33 FULL BODY: EXOSKELETON MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 34 EXOSKELETON MARKET, BY COMPONENT, 2021-2024 (USD MILLION)
  • TABLE 35 EXOSKELETON MARKET, BY COMPONENT, 2025-2030 (USD MILLION)
  • TABLE 36 EXOSKELETON MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 37 EXOSKELETON MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 38 EXOSKELETON MARKET, BY TYPE, 2021-2024 (THOUSAND UNITS)
  • TABLE 39 EXOSKELETON MARKET, BY TYPE, 2025-2030 (THOUSAND UNITS)
  • TABLE 40 POWERED: EXOSKELETON MARKET, BY BODY PART, 2021-2024 (USD MILLION)
  • TABLE 41 POWERED: EXOSKELETON MARKET, BY BODY PART, 2025-2030 (USD MILLION)
  • TABLE 42 POWERED: EXOSKELETON MARKET, BY MOBILITY, 2021-2024 (USD MILLION)
  • TABLE 43 POWERED: EXOSKELETON MARKET, BY MOBILITY, 2025-2030 (USD MILLION)
  • TABLE 44 POWERED: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 45 POWERED: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 46 POWERED: EXOSKELETON MARKET, BY TECHNOLOGY, 2021-2024 (USD MILLION)
  • TABLE 47 POWERED: EXOSKELETON MARKET, BY TECHNOLOGY, 2025-2030 (USD MILLION)
  • TABLE 48 PASSIVE: EXOSKELETON MARKET, BY BODY PART, 2021-2024 (USD MILLION)
  • TABLE 49 PASSIVE: EXOSKELETON MARKET, BY BODY PART, 2025-2030 (USD MILLION)
  • TABLE 50 PASSIVE: EXOSKELETON MARKET, BY MOBILITY, 2021-2024 (USD MILLION)
  • TABLE 51 PASSIVE: EXOSKELETON MARKET, BY MOBILITY, 2025-2030 (USD MILLION)
  • TABLE 52 PASSIVE: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 53 PASSIVE: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 54 EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 55 EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 56 HEALTHCARE: EXOSKELETON MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 57 HEALTHCARE: EXOSKELETON MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 58 HEALTHCARE: EXOSKELETON MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 59 HEALTHCARE: EXOSKELETON MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 60 HEALTHCARE: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 61 HEALTHCARE: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 62 HEALTHCARE: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 63 HEALTHCARE: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 64 HEALTHCARE: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 65 HEALTHCARE: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 66 HEALTHCARE: EXOSKELETON MARKET, FOR ROW, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 67 HEALTHCARE: EXOSKELETON MARKET, FOR ROW, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 68 DEFENSE: EXOSKELETON MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 69 DEFENSE: EXOSKELETON MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 70 DEFENSE: EXOSKELETON MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 71 DEFENSE: EXOSKELETON MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 72 DEFENSE: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 73 DEFENSE: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 74 DEFENSE: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 75 DEFENSE: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 76 DEFENSE: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2021-2024 (USD THOUSAND)
  • TABLE 77 DEFENSE: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2025-2030 (USD THOUSAND)
  • TABLE 78 DEFENSE: EXOSKELETON MARKET, FOR ROW, BY REGION, 2021-2024 (USD THOUSAND)
  • TABLE 79 DEFENSE: EXOSKELETON MARKET, FOR ROW, BY REGION, 2025-2030 (USD THOUSAND)
  • TABLE 80 INDUSTRIAL: EXOSKELETON MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 81 INDUSTRIAL: EXOSKELETON MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 82 INDUSTRIAL: EXOSKELETON MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 83 INDUSTRIAL: EXOSKELETON MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 84 INDUSTRIAL: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 85 INDUSTRIAL: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 86 INDUSTRIAL: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 87 INDUSTRIAL: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 88 INDUSTRIAL: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 89 INDUSTRIAL: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 90 INDUSTRIAL: EXOSKELETON MARKET, FOR ROW, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 91 INDUSTRIAL: EXOSKELETON MARKET, FOR ROW, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 92 CONSTRUCTION: EXOSKELETON MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 93 CONSTRUCTION: EXOSKELETON MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 94 CONSTRUCTION: EXOSKELETON MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 95 CONSTRUCTION: EXOSKELETON MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 96 CONSTRUCTION: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 97 CONSTRUCTION: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 98 CONSTRUCTION: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 99 CONSTRUCTION: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 100 CONSTRUCTION: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 101 CONSTRUCTION: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 102 CONSTRUCTION: EXOSKELETON MARKET, FOR ROW, BY REGION, 2021-2024 (USD THOUSAND)
  • TABLE 103 CONSTRUCTION: EXOSKELETON MARKET, FOR ROW, BY REGION, 2025-2030 (USD THOUSAND)
  • TABLE 104 OTHER VERTICALS: EXOSKELETON MARKET, BY TYPE, 2021-2024 (USD MILLION)
  • TABLE 105 OTHER VERTICALS: EXOSKELETON MARKET, BY TYPE, 2025-2030 (USD MILLION)
  • TABLE 106 OTHER VERTICALS: EXOSKELETON MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 107 OTHER VERTICALS: EXOSKELETON MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 108 OTHER VERTICALS: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 109 OTHER VERTICALS: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 110 OTHER VERTICALS: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 111 OTHER VERTICALS: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 112 OTHER VERTICALS: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2021-2024 (USD THOUSAND)
  • TABLE 113 OTHER VERTICALS: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2025-2030 (USD THOUSAND)
  • TABLE 114 OTHER VERTICALS: EXOSKELETON MARKET, FOR ROW, BY REGION, 2021-2024 (USD THOUSAND)
  • TABLE 115 OTHER VERTICALS: EXOSKELETON MARKET, FOR ROW, BY REGION, 2025-2030 (USD THOUSAND)
  • TABLE 116 EXOSKELETON MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 117 EXOSKELETON MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 118 NORTH AMERICA: EXOSKELETON MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 119 NORTH AMERICA: EXOSKELETON MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 120 US: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 121 US: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 122 CANADA: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 123 CANADA: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 124 MEXICO: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 125 MEXICO: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 126 EUROPE: EXOSKELETON MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 127 EUROPE: EXOSKELETON MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 128 UK: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 129 UK: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 130 GERMANY: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 131 GERMANY: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 132 FRANCE: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 133 FRANCE: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 134 ITALY: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 135 ITALY: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 136 POLAND: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 137 POLAND: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 138 NORDICS: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 139 NORDICS: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 140 REST OF EUROPE: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 141 REST OF EUROPE: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 142 ASIA PACIFIC: EXOSKELETON MARKET, BY COUNTRY, 2021-2024 (USD MILLION)
  • TABLE 143 ASIA PACIFIC: EXOSKELETON MARKET, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 144 CHINA: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 145 CHINA: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 146 JAPAN: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 147 JAPAN: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 148 SOUTH KOREA: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 149 SOUTH KOREA: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 150 INDIA: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 151 INDIA: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 152 AUSTRALIA: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 153 AUSTRALIA: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 154 INDONESIA: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD THOUSAND)
  • TABLE 155 INDONESIA: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD THOUSAND)
  • TABLE 156 MALAYSIA: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD THOUSAND)
  • TABLE 157 MALAYSIA: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD THOUSAND)
  • TABLE 158 THAILAND: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD THOUSAND)
  • TABLE 159 THAILAND: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD THOUSAND)
  • TABLE 160 VIETNAM: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD THOUSAND)
  • TABLE 161 VIETNAM: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD THOUSAND)
  • TABLE 162 REST OF ASIA PACIFIC: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD THOUSAND)
  • TABLE 163 REST OF ASIA PACIFIC: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD THOUSAND)
  • TABLE 164 ROW: EXOSKELETON MARKET, BY REGION, 2021-2024 (USD MILLION)
  • TABLE 165 ROW: EXOSKELETON MARKET, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 166 MIDDLE EAST: EXOSKELETON MARKET, BY COUNTRY, 2021-2024 (USD THOUSAND)
  • TABLE 167 MIDDLE EAST: EXOSKELETON MARKET, BY COUNTRY, 2025-2030 (USD THOUSAND)
  • TABLE 168 MIDDLE EAST: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD THOUSAND)
  • TABLE 169 MIDDLE EAST: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD THOUSAND)
  • TABLE 170 SOUTH AMERICA: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD MILLION)
  • TABLE 171 SOUTH AMERICA: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD MILLION)
  • TABLE 172 AFRICA: EXOSKELETON MARKET, BY COUNTRY, 2021-2024 (USD THOUSAND)
  • TABLE 173 AFRICA: EXOSKELETON MARKET, BY COUNTRY, 2025-2030 (USD THOUSAND)
  • TABLE 174 AFRICA: EXOSKELETON MARKET, BY VERTICAL, 2021-2024 (USD THOUSAND)
  • TABLE 175 AFRICA: EXOSKELETON MARKET, BY VERTICAL, 2025-2030 (USD THOUSAND)
  • TABLE 176 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR COMPANIES, JANUARY 2022-FEBRUARY 2025
  • TABLE 177 EXOSKELETON MARKET: DEGREE OF COMPETITION, 2024
  • TABLE 178 EXOSKELETON MARKET: REGION FOOTPRINT
  • TABLE 179 EXOSKELETON MARKET: VERTICAL FOOTPRINT
  • TABLE 180 EXOSKELETON MARKET: TYPE FOOTPRINT
  • TABLE 181 EXOSKELETON MARKET: BODY PART FOOTPRINT
  • TABLE 182 EXOSKELETON MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 183 EXOSKELETON MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 184 EXOSKELETON MARKET: PRODUCT LAUNCHES, JANUARY 2022-FEBRUARY 2025
  • TABLE 185 EXOSKELETON MARKET: DEALS, JANUARY 2022- FEBRUARY 2025
  • TABLE 186 EXOSKELETON MARKET: EXPANSIONS, JANUARY 2022-FEBRUARY 2025
  • TABLE 187 EXOSKELETON MARKET: OTHER DEVELOPMENTS, JANUARY 2022- FEBRUARY 2025
  • TABLE 188 EKSO BIONICS: COMPANY OVERVIEW
  • TABLE 189 EKSO BIONICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 190 EKSO BIONICS: PRODUCT LAUNCHES
  • TABLE 191 EKSO BIONICS: DEALS
  • TABLE 192 EKSO BIONICS: OTHER DEVELOPMENTS
  • TABLE 193 OTTOBOCK: COMPANY OVERVIEW
  • TABLE 194 OTTOBOCK: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 195 OTTOBOCK: PRODUCT LAUNCHES
  • TABLE 196 DIH MEDICAL: COMPANY OVERVIEW
  • TABLE 197 DIH MEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 198 DIH MEDICAL: DEALS
  • TABLE 199 COMAU: COMPANY OVERVIEW
  • TABLE 200 COMAU: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 201 COMAU: PRODUCT LAUNCHES
  • TABLE 202 MYOMO INC.: COMPANY OVERVIEW
  • TABLE 203 MYOMO INC..: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 204 MYOMO INC.: PRODUCT LAUNCHES
  • TABLE 205 MYOMO INC.: OTHER DEVELOPMENTS
  • TABLE 206 CYBERDYNE INC.: COMPANY OVERVIEW
  • TABLE 207 CYBERDYNE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 208 CYBERDYNE INC.: EXPANSIONS
  • TABLE 209 LIFEWARD LTD.: COMPANY OVERVIEW
  • TABLE 210 LIFEWARD LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 211 LIFEWARD LTD: DEALS
  • TABLE 212 HYUNDAI MOTOR GROUP ROBOTICS LAB.: COMPANY OVERVIEW
  • TABLE 213 HYUNDAI MOTOR GROUP ROBOTICS LAB.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 214 HYUNDAI MOTOR GROUP ROBOTICS LAB.: PRODUCT LAUNCHES
  • TABLE 215 HYUNDAI MOTOR GROUP ROBOTICS LAB.: DEALS
  • TABLE 216 B-TEMIA: COMPANY OVERVIEW
  • TABLE 217 B-TEMIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 218 REX BIONICS LTD.: COMPANY OVERVIEW
  • TABLE 219 REX BIONICS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 220 ABLE HUMAN MOTION: COMPANY OVERVIEW
  • TABLE 221 LAEVO EXOSKELETONS: COMPANY OVERVIEW
  • TABLE 222 GERMAN BIONIC SYSTEMS GMBH: COMPANY OVERVIEW
  • TABLE 223 LEVITATE TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 224 FOURIER: COMPANY OVERVIEW
  • TABLE 225 TREXO ROBOTICS: COMPANY OVERVIEW
  • TABLE 226 WANDERCRAFT: COMPANY OVERVIEW
  • TABLE 227 AGADE: COMPANY OVERVIEW
  • TABLE 228 EUROPE TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 229 GOGOA.EU: COMPANY OVERVIEW
  • TABLE 230 ARCHELIS INC.: COMPANY OVERVIEW
  • TABLE 231 P&S MECHANICS CO., LTD.: COMPANY OVERVIEW
  • TABLE 232 RB3D: COMPANY OVERVIEW
  • TABLE 233 JAPET MEDICAL DEVICES: COMPANY OVERVIEW
  • TABLE 234 PROTESO S.R.L.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 EXOSKELETON MARKET: RESEARCH DESIGN
  • FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY: SUPPLY-SIDE ANALYSIS
  • FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 2 (SUPPLY-SIDE)-IDENTIFICATION OF REVENUE GENERATED BY COMPANIES FROM SALES OF EXOSKELETON DEVICES
  • FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6 EXOSKELETON MARKET BREAKDOWN AND DATA TRIANGULATION
  • FIGURE 7 POWERED TYPE TO LEAD EXOSKELETON MARKET DURING FORECAST PERIOD
  • FIGURE 8 LOWER EXTREMITIES SEGMENT TO CAPTURE LARGEST MARKET SHARE THROUGHOUT FORECAST PERIOD
  • FIGURE 9 HEALTHCARE VERTICAL TO LEAD EXOSKELETON MARKET DURING FORECAST PERIOD
  • FIGURE 10 EUROPE TO ACCOUNT FOR LARGEST SHARE OF EXOSKELETON MARKET IN 2025
  • FIGURE 11 RISING DEMAND FOR PHYSICAL REHABILITATION AND MOBILITY SUPPORT SOLUTIONS TO DRIVE MARKET GROWTH
  • FIGURE 12 US AND HEALTHCARE VERTICAL TO HOLD LARGEST SHARE OF NORTH AMERICAN EXOSKELETON MARKET IN 2025
  • FIGURE 13 HEALTHCARE VERTICAL TO ACCOUNT FOR LARGEST SHARE OF EXOSKELETON MARKET IN ASIA PACIFIC THROUGHOUT FORECAST PERIOD
  • FIGURE 14 EXOSKELETON MARKET IN JAPAN TO GROW AT HIGHEST CAGR FROM 2025 TO 2030
  • FIGURE 15 EXOSKELETON MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16 DRIVERS AND THEIR IMPACT ON EXOSKELETON MARKET
  • FIGURE 17 RESTRAINTS AND THEIR IMPACT ON EXOSKELETON MARKET
  • FIGURE 18 OPPORTUNITIES AND THEIR IMPACT ON EXOSKELETON MARKET
  • FIGURE 19 CHALLENGES AND THEIR IMPACT ON EXOSKELETON MARKET
  • FIGURE 20 EXOSKELETON MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 21 EXOSKELETON MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 22 EXOSKELETON MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 23 PRICING RANGE OF EXOSKELETON OFFERED BY KEY PLAYERS, BY TYPE, 2024
  • FIGURE 24 AVERAGE SELLING PRICE TREND OF EXOSKELETON, BY TYPE, 2022-2024 (USD)
  • FIGURE 25 AVERAGE SELLING PRICE TREND OF POWERED EXOSKELETON, BY REGION, 2022-2024 (USD)
  • FIGURE 26 AVERAGE SELLING PRICE TREND OF PASSIVE EXOSKELETON, BY REGION, 2022-2024 (USD)
  • FIGURE 27 PORTER'S FIVE FORCES ANALYSIS: EXOSKELETON MARKET
  • FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR EXOSKELETONS FOR TOP THREE VERTICALS
  • FIGURE 29 KEY BUYING CRITERIA FOR EXOSKELETONS FOR TOP THREE VERTICALS
  • FIGURE 30 FUNDS ACQUIRED BY COMPANIES IN EXOSKELETON
  • FIGURE 31 IMPORT DATA FOR HS CODE 9021-COMPLIANT PRODUCTS FOR TOP 5 COUNTRIES, 2020-2024
  • FIGURE 32 EXPORT DATA FOR HS CODE 9021-COMPLIANT PRODUCTS FOR TOP 5 COUNTRIES, 2020-2024
  • FIGURE 33 NUMBER OF PATENTS APPLIED AND GRANTED IN EXOSKELETON MARKET, 2014-2024
  • FIGURE 34 AI USE CASES
  • FIGURE 35 MOBILE SEGMENT TO HOLD LARGER SHARE OF EXOSKELETON MARKET IN 2030
  • FIGURE 36 LOWER EXTREMITIES BODY PART SEGMENT TO HOLD LARGEST SHARE OF EXOSKELETON MARKET IN 2030
  • FIGURE 37 ACTUATORS TO HOLD LARGEST SHARE OF EXOSKELETON MARKET IN 2030
  • FIGURE 38 POWERED EXOSKELETONS TO HOLD LARGER SHARE OF EXOSKELETON MARKET IN 2030
  • FIGURE 39 HEALTHCARE VERTICAL TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
  • FIGURE 40 EXOSKELETON MARKET: REGIONAL SNAPSHOT
  • FIGURE 41 NORTH AMERICA: EXOSKELETON MARKET SNAPSHOT
  • FIGURE 42 EUROPE: EXOSKELETON MARKET SNAPSHOT
  • FIGURE 43 ASIA PACIFIC: EXOSKELETON MARKET SNAPSHOT
  • FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS IN EXOSKELETON MARKET, 2019-2023
  • FIGURE 45 MARKET SHARE ANALYSIS OF MAJOR PLAYERS, 2024
  • FIGURE 46 COMPANY VALUATION, 2024
  • FIGURE 47 FINANCIAL METRICS (EV/EBITDA), 2024
  • FIGURE 48 EXOSKELETON MARKET: BRAND/PRODUCT COMPARISON
  • FIGURE 49 EXOSKELETON MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 50 EXOSKELETON MARKET: COMPANY FOOTPRINT
  • FIGURE 51 EXOSKELETON MARKET: COMPANY EVALUATION MATRIX (SMES/STARTUPS), 2024
  • FIGURE 52 EKSO BIONICS: COMPANY SNAPSHOT
  • FIGURE 53 DIH MEDICAL: COMPANY SNAPSHOT
  • FIGURE 54 MYOMO INC.: COMPANY SNAPSHOT
  • FIGURE 55 CYBERDYNE INC.: COMPANY SNAPSHOT
  • FIGURE 56 LIFEWARD LTD.: COMPANY SNAPSHOT
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!